Accedi ai contenuti
Registrati »
Accedi ai contenuti
Registrati »
Home2020Ottobre

Introduction: In this study, we aim to report the outcome of COVID-19 in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitor (TKI). Method: The data of 16 laboratory-confirmed COVID-19 patients with CML receiving TKI and age, gender, and comorbid disease matched COVID-19 patients without cancer at a 3/1 ratio (n = 48), diagnosed between March 11, 2020 and May 22, 2020 and included in

Shortages of medicines have become a major public health challenge. The aim of this study was to survey national measures to manage and combat these shortages. A questionnaire survey was conducted with public authorities involved in the Pharmaceutical Pricing and Reimbursement Information (PPRI) network. Reponses relating to measures as of March/April 2020 were received from 24 countries (22 European countries,

Coronavirus/Tracing,Testing e Treating, i prezzi del vaccino anti-Covid, le raccomandazione dell'OMS, le stime e i numeri della seconda ondata e molto altro nella rassegna stampa #13